Hydrochlorothiazide Aurovitas

Hydrochlorothiazide Aurovitas is a prescription medication that contains the active ingredient hydrochlorothiazide, supplied as an oral dosage form. It belongs to the thiazide diuretic class and is marketed in the European Union. The product is used to manage fluid balance and blood pressure, and it is available only with a doctor's prescription.

Hydrochlorothiazide Aurovitas is indicated for several conditions where reduction of excess fluid or control of blood pressure is needed.

- Treatment of hypertension (high blood pressure). - Management of edema associated with congestive heart failure. - Reduction of fluid retention in renal disease such as nephrotic syndrome. - Relief of ascites and peripheral edema in liver cirrhosis. - Adjunct therapy for patients requiring additional diuretic effect.

Hydrochlorothiazide Aurovitas may cause a range of adverse reactions, some of which are more frequently observed than others.

Common: - Increased frequency of urination. - Dizziness or light‑headedness, especially when standing. - Headache. - Mild electrolyte disturbances such as low potassium (hypokalemia). - Fatigue or weakness. - Elevated blood glucose levels.

Serious: - Severe dehydration or electrolyte imbalance (e.g., hyponatremia, hypokalemia). - Acute gout attacks. - Pancreatitis. - Allergic reactions including rash, Stevens‑Johnson syndrome, or anaphylaxis. - Blood dyscrasias such as leukopenia or thrombocytopenia.

Before starting Hydrochlorothiazide Aurovitas, certain health considerations should be reviewed.

- Assess renal function; use with caution in patients with impaired kidney function. - Monitor serum electrolytes, especially potassium and sodium, during therapy. - Patients with a history of gout may experience flare‑ups. - Caution is advised in diabetic patients as blood glucose may rise. - Pregnancy category is unknown; avoid use unless clearly needed. - Elderly individuals may be more susceptible to volume depletion and orthostatic hypotension. - Document any known sulfonamide allergy, as cross‑reactivity can occur.

Hydrochlorothiazide Aurovitas can interact with several other medications, affecting its safety and efficacy.

Avoid: - Lithium, because thiazides can increase lithium concentrations and risk toxicity. - Other potent diuretics (e.g., loop diuretics) that may cause excessive fluid loss. - High‑dose corticosteroids, which can exacerbate electrolyte disturbances.

Use with caution: - Antihypertensive agents (ACE inhibitors, ARBs, beta‑blockers) – may enhance blood‑pressure‑lowering effect. - Digoxin – risk of hypokalemia‑induced digoxin toxicity. - Antidiabetic drugs – possible increase in blood glucose requiring dose adjustment. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) – may reduce diuretic efficacy and affect renal function. - Alcohol – can increase risk of orthostatic hypotension.